- Poster presentation
- Open Access
The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF)
Pediatric Rheumatology volume 13, Article number: P22 (2015)
Familial Mediterranean Fever (FMF) is a genetic disorder characterized by recurrent attacks of fever and pain, which is most common in those of Sephardic Jewish, Armenian, Turkish or Arabic descent. Although colchicine is the mainstay of treatment for FMF, an estimated 5 to 15% of patients have an incomplete response to colchicine (e.g. colchicine-resistance FMF [cr-FMF]).[1, 2]
To determine the impact of cr-FMF on patients’ or caregivers’ lives, to describe patient's journey from first onset of symptoms to present, and to identify areas for improvement in cr-FMF patient care.
Patients and methods
Patients with cr-FMF or their caregivers (paediatric patients) (N=16) were recruited through rare disease experts and patient support groups. Patients completed a 20 page pre-interview questionnaire and an in-depth 90 minute interview. Complete data (n=14) were quantified with topics focused on symptoms, diagnosis process, treatment experience, treatment needs and impact on wellbeing.
The majority of patients were adults (n=14) with a family history of FMF (n=14). The disease generally starts in childhood, with 65% of patients experiencing symptoms before 10 years. Attacks occurred with variable frequency, ranged from weekly to every 3-4 months, lasting between 12-72 hours. Reported triggers included physical or emotional stress, or menstruation or occured spontaneously. Commonly reported symptoms were stomach, fever, joint pain, difficulty breathing and chest and back pain. Diagnosis delays were also variable (4 months-44 yrs), with half of patients experiencing delays of ~5 years. Flares were extremely debilitating and patients were often bedridden, leading to missed work and school. Entire families were impacted, especially caregivers. Patients/caregivers were often dependant on family for support and financial assistance. Most patients continue to be treated with colchicine despite only partial response and distressing side-effects. They expressed the need for treatments that provided not only rapid relief during flares, but also prevented or reduced attacks.
Patients with cr-FMF reported a significant impact of the disease on physical, social, emotional, and practical/financial aspects of their lives. In their journey with cr-FMF, they commonly experienced diagnostic delays and misdiagnoses. Therapeutic options with improved efficacy and fewer side-effects are needed for the treatment of cr-FMF.
Jacobs Z, et al: Curr Allergy Asthma Rep. 2010, 10 (6): 398-404. 10.1007/s11882-010-0141-z.
Ben-Chetrit E, et al: Clin Exp Rheumatol. 2008, 26 (4): S49-S51.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Dandekar, P., Gregson, J., Campbell, R. et al. The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF). Pediatr Rheumatol 13 (Suppl 1), P22 (2015). https://doi.org/10.1186/1546-0096-13-S1-P22
- Familial Mediterranean Fever
- Financial Assistance
- Emotional Stress
- Entire Family